Yiyeon Pharmaceutical pursues asset securitization of Chungju plant... "Secure ₩100B, will create business synergy"
Predicted impact: Medium
Plant securitization targeting ₩100B, about 54% of market value, though it is financing, not equity.
Reyon Pharmaceutical이연제약
102460 · KOSPI · ₩102460 · 이연제약
₩9,360▼ ₩320 (3.31%)End-of-day · Oct 29, 2026 · End-of-day prices.
Eyes Pharma Partner Elixirgen Wins 'Bayer Corlab Connect Seoul'
Predicted impact: Medium· Actual: −9.3% vs sector, volume 1.3× normal (5 trading days)
Amended convertible bond issue decision; dilution size not stated in data.
Also known as: Reyon Pharmaceutical / 이연제약 / 102460 / KRX:102460
Source: KRX statistical information